Hansson L - Search Results

1

Characteristics of 15,314 hypertensive patients at high coronary risk. The VALUE trial. The Valsartan Antihypertensive Long-term Use Evaluation.

Kjeldsen SE, Julius S, Brunner H, Hansson L, Henis M, Ekman S, Laragh J, McInnes G, Smith B, Weber M, Zanchetti A. Kjeldsen SE, et al. Among authors: hansson l. Blood Press. 2001;10(2):83-91. doi: 10.1080/08037050152112069. Blood Press. 2001. PMID: 11467764 Free article. Clinical Trial.

2

The Hypertension Optimal Treatment (HOT) Study--patient characteristics: randomization, risk profiles, and early blood pressure results.

Hansson L, Zanchetti A. Hansson L, et al. Blood Press. 1994 Sep;3(5):322-7. doi: 10.3109/08037059409102281. Blood Press. 1994. PMID: 7866597 Free article. Clinical Trial.

3

Characteristics of an ideal antihypertensive therapy for elderly hypertensives.

Hansson L, Zanchetti A. Hansson L, et al. Blood Press Suppl. 1995;3:68-72. Blood Press Suppl. 1995. PMID: 8535546

4

Stroke is more common than myocardial infarction in hypertension: analysis based on 11 major randomized intervention trials.

Kjeldsen SE, Julius S, Hedner T, Hansson L. Kjeldsen SE, et al. Among authors: hansson l. Blood Press. 2001;10(4):190-2. doi: 10.1080/08037050152669684. Blood Press. 2001. PMID: 11800055 Free article. Review. No abstract available.

5

The Hypertension Optimal Treatment (HOT) Study: 12-month data on blood pressure and tolerability. With special reference to age and gender.

Hansson L, Zanchetti A. Hansson L, et al. Blood Press. 1995 Sep;4(5):313-9. doi: 10.3109/08037059509077613. Blood Press. 1995. PMID: 8535554 Free article. Clinical Trial.

6

The Hypertension Optimal Treatment (HOT) Study: 24-month data on blood pressure and tolerability.

Hansson L, Zanchetti A. Hansson L, et al. Blood Press. 1997 Sep;6(5):313-7. doi: 10.3109/08037059709062088. Blood Press. 1997. PMID: 9360003 Free article. Clinical Trial.

7

Hypertension optimal treatment (HOT) study: home blood pressure in treated hypertensive subjects.

Kjeldsen SE, Hedner T, Jamerson K, Julius S, Haley WE, Zabalgoitia M, Butt AR, Rahman SN, Hansson L. Kjeldsen SE, et al. Among authors: hansson l. Hypertension. 1998 Apr;31(4):1014-20. doi: 10.1161/01.hyp.31.4.1014. Hypertension. 1998. PMID: 9535429 Clinical Trial.

8

Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT study. Hypertension Optimal Treatment.

Kjeldsen SE, Kolloch RE, Leonetti G, Mallion JM, Zanchetti A, Elmfeldt D, Warnold I, Hansson L. Kjeldsen SE, et al. Among authors: hansson l. J Hypertens. 2000 May;18(5):629-42. doi: 10.1097/00004872-200018050-00017. J Hypertens. 2000. PMID: 10826567 Clinical Trial.

9

Treatment of hypertension in patients with type-2 diabetes mellitus.

Kjeldsen SE, Os I, Farsang C, Mallion JM, Hansson L, Sleight P. Kjeldsen SE, et al. Among authors: hansson l. Blood Press. 2000;9(6):363-4. Blood Press. 2000. PMID: 11212066 No abstract available.

10

Influence of gender on prevention of myocardial infarction by antihypertensives and acetylsalicylic acid: the HOT study.

Kjeldsen SE, Warnold I, Hansson L; HOT Study Group. Hypertension Optimal Treatment Study Group. Kjeldsen SE, et al. Among authors: hansson l. J Gend Specif Med. 2000 Nov-Dec;3(8):35-8. J Gend Specif Med. 2000. PMID: 11253266 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,351 results

Search Page

Filters